Segovia, Wenelyn L.

HRN: 26-56-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
MUPIROCIN 2%, 15G (TUBE)
02/28/2026
03/06/2026
TOPICAL
2%
BID X 7days
Sp PLTCS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines